Lloyd Czaplewski is an International Opinion Leader & successful Scientist Entrepreneur in the antibacterial R&D sector.

"Over 15-years experience in antibacterials has taught me what works & what does not. That is invaluable expertise that clients can benefit from"

Key successes:

Target validation - over 300 potential targets analysed in detail

Screening - over 150,000 compounds screened against multiple bacterial pathogens & targets

Created class-leading antibacterial DNA supercoiling GyrB/ParE ATPase inhibitors with competitive preclinical efficacy and pharmacology - ready for candidate nomination with a strong unrelated back-up series.

Created the first efficacious inhibitors of bacterial cell division that target the GTPase FtsZ

Devised portfolio growth strategies to address Gram-negatives  targeting multi-drug resistant strains eg NDM-1, using innovative chemistry

Commercial success - building & selling an antibacterial business